These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6198637)

  • 21. Long term outcome of localized aggressive non-Hodgkin lymphoma treated with a short weekly chemotherapy regimen (doxorubicin, cyclophosphamide, bleomycin, vincristine, and prednisone) and involved field radiotherapy: result of a Gruppo Italiano Multiregionale per lo Studio dei Linfomi e Leucenie (GIMURELL) study.
    Cabras MG; Mamusa AM; Vitolo U; Freilone R R; Dessalvi P; Orsucci L; Tonso A; Levis A; Liberati M; Lay G; Angelucci E
    Leuk Lymphoma; 2009 Sep; 50(9):1475-81. PubMed ID: 19579074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Longo DL; DeVita VT; Young RC
    N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of non-Hodgkin's lymphomas with CHOP-bleo. Experience in 16 patients].
    González Brito G; Marsá Vilá L; Chávez MI; Batista López N; Hernández Nieto L
    Sangre (Barc); 1985; 30(3):367-8. PubMed ID: 2412301
    [No Abstract]   [Full Text] [Related]  

  • 24. Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?
    Eichenauer DA; Engert A
    Leuk Lymphoma; 2009 Nov; 50(11):1733-4. PubMed ID: 19883301
    [No Abstract]   [Full Text] [Related]  

  • 25. A clinical phase II study of ProMACE-CytaBOM.
    Dahlberg S; Miller TP; Fisher RI
    J Clin Oncol; 1991 May; 9(5):888. PubMed ID: 1707958
    [No Abstract]   [Full Text] [Related]  

  • 26. Diffuse large-cell lymphoma: more CHOP-Bleo is not better.
    Coltman CA
    J Clin Oncol; 1986 Oct; 4(10):1439-40. PubMed ID: 2428946
    [No Abstract]   [Full Text] [Related]  

  • 27. Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: the Stanford experience.
    Kwak LW; Wilson M; Weiss LM; Doggett R; Dorfman RF; Warnke RA; Horning SJ
    J Clin Oncol; 1991 Aug; 9(8):1426-31. PubMed ID: 1712837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
    Bron D; Vandenheule B; Stryckmans P
    Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298
    [No Abstract]   [Full Text] [Related]  

  • 29. A ten-year update of CHOP-BLEO in the treatment of diffuse large-cell lymphoma.
    Hryniuk WM
    J Clin Oncol; 1987 Apr; 5(4):682. PubMed ID: 2435859
    [No Abstract]   [Full Text] [Related]  

  • 30. Intensive weekly combination chemotherapy for patients with intermediate-grade and high-grade non-Hodgkin's lymphoma.
    Sweetenham JW; Mead GM; Whitehouse JM
    J Clin Oncol; 1991 Dec; 9(12):2202-9. PubMed ID: 1720454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CBVPM/AVBP versus HCOMLA chemotherapy in non-Hodgkin lymphoma patients.
    Pawelski S; Konopka L; Pakulska J; Gutkowska J
    Chemioterapia; 1987 Jun; 6(2 Suppl):716-9. PubMed ID: 2475265
    [No Abstract]   [Full Text] [Related]  

  • 32. ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma.
    Prokocimer M; Modan M; Rusoshansky S; Bairey O; Shaklai M
    Anticancer Res; 1989; 9(4):1233-5. PubMed ID: 2479327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy.
    Gerhartz HH; Thiel E; Brittinger G; Dörken B; Engelhard M; Engert W; Enne W; Fuchs R; Hagen-Aukamp CH; Huhn D
    Blut; 1988 Mar; 56(3):139-42. PubMed ID: 2451551
    [No Abstract]   [Full Text] [Related]  

  • 34. [Non-Hodgkin's lymphomas. Results of alternating chemotherapy versus sequential chemotherapy].
    Avilés A; Díaz-Maqueo JC; Torras V; Rodríguez L; López Vancell D
    Sangre (Barc); 1990 Aug; 35(4):245-9. PubMed ID: 1703327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
    Shapiro CL; Yeap BY; Godleski J; Jochelson MS; Shipp MA; Skarin AT; Canellos GP
    Cancer; 1991 Aug; 68(4):699-705. PubMed ID: 1713121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
    Miller TP; Dahlberg S; Weick JK; Files JC; Eyre HJ; Pendergrass KB; Fisher RI
    J Clin Oncol; 1990 Dec; 8(12):1951-8. PubMed ID: 1700079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase III trial of cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) versus cisplatin, etoposide, bleomycin and prednisone (CisEBP) for the treatment of advanced non-Hodgkin's lymphoma of high grade malignancy. The Danish Lymphoma Study Group.
    Andersen J; Thorling K; Bentzen SM; Brincker H; Christensen BE; Pedersen M
    Acta Oncol; 1990; 29(8):995-9. PubMed ID: 1703769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
    Konopka L; Pawelski S
    J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
    [No Abstract]   [Full Text] [Related]  

  • 39. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
    O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
    J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide, vincristine, adriamycin, and prednisone (CHOP) with and without intermediate dose methotrexate for the treatment of non-Hodgkin's lymphomas of diffuse histology.
    Gomez GA; Barcos M; Han T; Henderson ES
    Cancer; 1987 Jul; 60(1):18-24. PubMed ID: 3581030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.